Belimumab Before or After Immunosuppressant Save
Dr. Yuz Yusof reports on abstract 0803 (Improved Efficacy and Safety Outcomes in Patients with SLE Treated with Belimumab (BEL) Versus Immunosuppressants (IS), in Addition to Antimalarials (AM) and Glucocorticoids (GC): A Post Hoc Summary of Five Phase 3 Trials) presented at the 2025 ACR Convergence meeting in Chicago.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.